<h2 style='margin-top: 1em'>Markscheme</h2>
<div class='question' style='padding-left: 20px;'>
<p>catabolism/catabolic</p>
<p><em><strong>[1 mark]</strong></em></p>
<div class='question_part_label'>a.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>alanine</p>
<p>&nbsp;</p>
<p><em>Do <strong>not</strong> accept ala.</em></p>
<p><strong><em>[1 mark]</em></strong></p>
<div class='question_part_label'>b.i.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>Lys/lysine</p>
<p>pH &laquo;buffer&raquo; &lt;&nbsp;p<em>I</em> &laquo;<em>Lys</em>&raquo;<br /><em><strong>OR</strong></em><br />buffer more acidic than Lys &laquo;at isoelectric point&raquo;<br /><em><strong>OR</strong></em><br />&laquo;Lys&raquo; exists as&nbsp;<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAKcAAABNCAYAAADDyXQIAAAO0UlEQVR4Ae2dC5BX4xvHn+626KqLLCW5lBISIpeZkp3chQxyTUhG7mOWJLlESEKbRLLut2hJJjHJrUhSmZIaQkqN0kiS9z+fZ/7vcfa379n9/XZPvz37O+eZOXvO770+7/s8570879nnW8sYYyShpAci2AO1I8hTwlLSA9oDiXImihDZHkiUM7KiSRhLlDPRgcj2QCSU84ILLohsByWMVV8PREI5q6/5Sc1R7oFEOaMsnZjzlihnzBUgys2vlW0jvGt9OXfuXDnqqKO8fmratKmMGzfO+508xLMHsq6crm5GYZ955hlXVBIW4x5IpvUYCz/qTU+UM+oSijF/kVDOJk2axFgESdODeiASa84g5pLwePdAJEbOKIjgp59+kiFDhsgee+whtWrVkl133VUuvvhiWbVqVSn23n77bTn00ENl+fLlpcLtj9tvv13jSZMNWrt2rdx4443SoUMH5XuXXXaRU045RT7++OPA6p999lnp2bOn5OXlSd26deXAAw+UUaNGyR9//BGYZ968edKgQQOto1WrVtK/f3/58MMPA9OHEZGWciKsyy+/PLC+3XffPW2BUFaLFi3k119/dZaXSVnOApLAnOmButXRkg0bNsjVV18tL730UnVUX6bOWbNm6Ujw77//Sr9+/XT0/PHHH+XFF18URsrZs2dL586dNR+8f/HFF7Jly5Yy5RCwcuVKjXdGhhwI32eddZb89ddfUlBQoG1Yv369vPnmm3LMMcfI008/Leeff75X659//ilnn322lJSUSMeOHXVmYDT88ssv5bbbbpOnnnpK3nrrLa+tNuOjjz4q11xzjdSuXVtuuOEG+eWXX2TGjBny2muvySWXXCJFRUU6AjNiu+iwww7T4FtvvdUVHRhWLcpZr149efnll/Wic6uT6GimqP3331+mTZsmrVu39tj5+uuv5bjjjpNzzz1XvvrqKy+8uh/gGYLvPffcUxWqXbt2HlvMSscff7wMHjxYjj76aLFxQ4cOVaV68MEHPWWzmT755BM57bTT5Mwzz9SXiykf4uVEMQmfMGGCcEAC8XIOGzZMJk6cKI0bN5aHHnpIw0P9wwlRRSQiZvDgwYHJ2rZta7p3765XYKL/R1DWwIEDTYcOHUyzZs3MDz/8UCpLJmWVyljJH4WFhaZOnTpm2bJlzhLuuusuk5+fb1asWKHxU6dO5d9azMKFC53paRvxXDuK4NnyvXTpUmc1c+fONY0bNzbFxcUav3LlSm1neXKcNm2a8j1+/HivzC5duph27dqZrVu3emH+h969e2u5y5cv9weH8pzWmjPUt0FEF+KTJ0+WTZs2yRVXXBF28RmVN336dF0v77PPPs58N910kzDFs+GICsGz5ZsR30VHHnmkMMUz6kPvvPOObN++XZdTrvSEnXTSSdK2bVtdzvB7xYoV8s033+jSoH79+s5sjJ6UO2XKFGd8VQLTntYZvrmCaLfddguKcoYfe+yxOl0wxVAuU5CL2EDtCLL/17ds2TJdewXVwW7WRbxU7IxTCWGmUlht8PNMHVgTyiM/7/DVqFEj6dKlS2AW1pSHH364vPfee5pm0aJFej/kkEMC8yBH6PPPPw9MU9kId887SuvevbucfPLJjhiRBx54wAu35ohBgwbJG2+8IRjYR4wYoWYaL9H/H+6++24dAa677jrp3bu37L333qlJmBvLhIUZwNqpYcOGYRZZpqyw22A3Y5nwjVxcL1MqszvvvLNs3rxZg+29vHw2zso9tbyq/M5IObHhuai8EdWV3oaxUyQvm45LL71U3n//fRuVtXvLli3lt99+y7g+NgfYB1OJj1imTp2aGhzqb3iGMuGbTQvLqIoIa0Tz5s01GXmg8vJZHrALh02hrzlZo3H9/PPP8sEHH6h5Yvjw4d5UkdoApgXWLRh0d8iOL7XClN/dunWTzz77LCX0v5/r1q1T88ucOXP+C6zmJ3iuiG9YvPLKK+WJJ55QbjHnYEoqr63//POPfPrpp2qgJ1OPHj0070cffaR31x/MbJCd3l1pKhsWunJiP+N6/PHHtZEnnnii9OnTRzhhCKLRo0fLwQcfrLa28t7SoPxVCcfut3Tp0sCXBxsfZi8EFxWCZ8s3GyMXMTAwumN3hTATscTiNOnvv/92ZZFHHnlEN1HMYhD7CJZyTz75pFeOPyNTOUs2RtgLL7zQHxXOczp7fswi5Zkggsw/CxYsMKNHj1azEaYMKKisJUuWmLy8PI1P1yyVDu8VpcFE0qlTJ9OqVSvz6quvmu3bt2uWbdu2GUwq9erVM3369PGKiYIpCZ4t35iLpkyZYuDX0uuvv25atmxpWrRoYdauXWuDzcSJE7V/+/bta77//nsvfOPGjWbEiBFqEurXr58XzgNyo2/at29vZsyY4cXNmTPHdOvWTcubPHmyFx7mQ1rGuCCFsowEKeewYcNMr169TI8ePQyKCpVX1pgxY7KunPCEDRNbHrwhVF4ObLD87tq1q1mzZo1tqomCclpm4Bt7MXzCL3wjC343b97czJ492yb17vaFI81+++2nCtagQQPNU1BQYDZt2uSltQ/IzpZLHa1bt9b0jRo1MpMmTbLJQr+n9VUSx3UswjmNcBEmB059IJfdjbXkpEmTZPHixXr6EFQWx4cLFixQk0dQWa76wwhjZ4qtjn8ZwT7YrFkztSAMHDhQdtppJ68Kjvqef/55wcLgMp+98MIL3vHl/fff7+XbUQ/s3J977jlds3MyhLnoiCOO0GPFoE0KUz1t5dRr69atsu++++rHIlhMgoj+IZ4TIr6NwOR03nnn6QcyQXmqGp6WcmZSycMPP6zJzznnHO8ocP78+dphUVq3ZdKmJG319EDoyslZLnTQQQcJisri+6KLLpKNGzfqKUX1NDOptSb2QOjKuWTJEu2HU089VfjWkKMtduKvvPKKN5JGvaM40QnbcB71NkeRv9CV0zaS9SMf5LJes1/F2Lio3xPljIaEdphyRqN5leMiUc7K9VvYuUI3wofNYFJefHsgUc74yj7yLU+UM/Iiii+DiXLGV/aRb3minJEXUXwZTJQzvrKPfMsT5Yy8iOLLYKKc8ZV95FueKGfkRRRfBhPljK/sI9/yRDkjL6L4MpgoZw7I3uVnPweaJYly5oIUc7QNiXLmqGBzoVmJcuaCFHO0Dcn3nA7BRvl7Ttf6MldxnBLlrGHK6WBXUNhcxHFKpnWXtJOwSPRAopyREEPChKsHEuV09UoNC8tVHKdkzVnDFDFO7CYjZ5ykXcPaGkvlfOyxx+SEE04oJSr+zx7/Qb169VJ/Q7isxmvJ2LFjy7g/xH+S9bVeqhAR9VsEQBb+iyoioFHwuZQJYeYCyMt6HfbnxVcS8bg5tMRO3uXTycbjvJc8uHmMGsVSOaMmhIQfdw/ETjmBEQSsye8BDpApnNzi0wnvvwA/XXXVVQoKde2118rpp59eavTE2ax1u5ParYxeeOXjXhGNGzdOPQ+D9ZMJrV692uljP5MyakLa2Cknnnj79u1byp/79ddfr56NQWzDxSEefnFChne8wsJCBVWw3vPCFGr79u0VegVPwpk4/MfdJH7nQVvLZYqNcjJicrGuxFe6JdDQ8JvOSIkraz8BfTJy5Ehdh3777bf+qNCeQUcDJADIm3QJyMA2bdoohtPvv/+ebrYaly42yolTVy6cwlo3jUjr3XfflW3btqkjVJf0UFDACqzjf1eaqoQBZwjeJs512ZSlQzhv5biSpUOmG6p0yo9KmrShXqLCcGX5AEgUwusvCmfpu+++00cXbItN47oDrsVuHuIZ78AQ6BuZEpYDMJsAmoK/dAhsy8suu0xBCc444wxFXwvKt2bNGt2RB8VHNfw/KUWVw5D4YgPDZZXIFovbacjvWtvGlXcnPQrNhanGPgPP5yec56JEgE+Rhyk51Qx0wAEHaBZcjvuJ6R5X50E4T/fcc49O72zgSBtE1M1aG7wn7v4rFfiMte+AAQMUWx1cdcxu1UWxGTnBRYJYq/nJKhNrz/Lsgf48PKM0ri+B8H/PRsrSqFGjdPcOJEudOnWEzRcWAP8yYa+99tLkdhS3eUHBA3cziPDPzkYNZbrlllt0fexKi3ICcOYCOUPx/RsrP4YUCg+EC7igjNTZptiMnEEda6dmIJ2DCEwlNkuV2XwAKIDZilGLtS4KYpcYQfURft999yl4gwty0Z/PYhKhZBaz0h+f6XOmGFKZlp9J+tiMnHaEZP3lJxQmPz9fxowZo0BS/vUo6ZjmUBRQcy3WuD9/Rc9+eypp2VylgqNit4SsB2hG2TvuuENARxsyZEhFVUhRUZEir4GEV1ViZIdA2pg5c6aCm917771VLbZS+WMzcqIQXKnGc44pUSBGTvzY+1F/2aBgE121apWAMldVmjVrltpQMU/5CUWAAL8FRhoIFZYHQAKmQ7w0rA2BqAmLMLkx3WMZqMyMEQYfsRk5CwoKtL/uvPNOPe3xwz0DS4NgOZPu2rWrwvCRGAQQkHkRPPB8VSHO2oHBZolgMSVteZizwGbq2bOnKmTnzp2FdSjTNCM3J1JcnTp1slnK3Dnh4sw/LFBYi0PKnZcFDKmsU+iwWxEtEBQ2LuAC/TB5fnaJByqvsLDQ3HzzzYpOtn79en8SfS4pKTHTp08vE04AMImgvHG3RHkgrM2cOdMGeXfqrF+/vhk+fLiGAdnnvxo2bGjy8/PNyJEjNX7+/Plm9erVXn7/w+bNm01qPPCACxcu9Ccr9bxu3TrNs2HDBg0fO3ZsKcS6efPmKexgqUxZ+pEWvGCWeMlKNYMGDTL9+/fPSl1UMmHCBMWNBArQRWBONm3a1KAkLgLOr6ioyBW1Q8KAgxw6dKhigG7ZssUMGDDAADtYHRQ75WTUadKkiVm0aFFW+hvMSDAi27RpU+qichQSYNXi4uJAXrKtnIsXLzYdO3ZUvuAbZWV0rw6K5Zfw48ePl5KSkqwgyvGFkovY/PAVFEenxcXFriQahq0xLy9Pr8BEIUdEBUMqlsoZsiwrXRxn4+yG/ZuzSheWgxkT5cxBoeZKk2Jj58wVgcWpHYlyxknaNayt/wM4Ooyb91ibfwAAAABJRU5ErkJggg==" /></p>
<p><em><strong>OR</strong></em></p>
<p>&laquo;Lys&raquo; charged positively/has +1/1+ &laquo;overall&raquo; charge &laquo;and moves to negative electrode&raquo;</p>
<p>&nbsp;</p>
<p><em>Do <strong>not</strong> apply ECF from M1.</em></p>
<p><em>Accept converse argument.</em></p>
<p><em>Do <strong>not</strong> accept just &ldquo;has H<sub>3</sub>N<sup>+</sup> group&rdquo; for M2 (as H<sub>3</sub>N<sup>+</sup> is also present in&nbsp;zwitterion).</em></p>
<p><em>Do <strong>not</strong> penalize if COOH is given in the structure of lysine at pH 6 instead of&nbsp;COO<sup>&ndash;</sup>.</em></p>
<p><strong><em>[2 marks]</em></strong></p>
<div class='question_part_label'>b.ii.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>highest <span style="text-decoration: underline;">frequency</span> of <span style="text-decoration: underline;">successful</span> collisions between active site and substrate<br /><em><strong>OR</strong></em><br />highest <span style="text-decoration: underline;">frequency</span> of collisions between active site and substrate with sufficient&nbsp;energy/\(E \geqslant {E_{\text{a}}}\)&nbsp;<em><strong>AND</strong> </em>correct orientation/conformation<br /><em><strong>OR</strong></em><br />optimal shape/conformation of the active site &laquo;that matches the substrate&raquo;<br /><em><strong>OR</strong></em><br />best ability of the active site to bind &laquo;to the substrate&raquo;</p>
<p>&nbsp;</p>
<p><em>Accept &ldquo;number of collisions per unit&nbsp;time&rdquo; for &ldquo;frequency&rdquo;.</em></p>
<p><em>Do <strong>not</strong> accept &ldquo;all active sites are occupied&rdquo;.</em></p>
<p><strong><em>[1 mark]</em></strong></p>
<div class='question_part_label'>c.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>ascorbic acid/vitamin C</p>
<p><em><strong>[1 mark]</strong></em></p>
<div class='question_part_label'>d.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>react/bind/chelate with enzyme<br /><em><strong>OR</strong></em><br />disrupt ionic salt bridges<br /><em><strong>OR</strong></em><br />affect shape of tertiary/quaternary structures<br /><em><strong>OR</strong></em><br />precipitate enzymes<br /><em><strong>OR</strong></em><br />break/disrupt disulfide bridges/bonds</p>
<p>&nbsp;</p>
<p><em>Do <strong>not</strong> accept &ldquo;changes shape of active&nbsp;site&rdquo; by itself.</em></p>
<p><strong><em>[1 mark]</em></strong></p>
<div class='question_part_label'>e.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>&laquo;use of&raquo; host-guest chemistry<br /><em><strong>OR</strong></em><br />chelation &laquo;therapy&raquo;</p>
<p>&nbsp;</p>
<p><em>Accept specific medication/chelating&nbsp;agent such as EDTA, CaNa<sub>2</sub> EDTA, succimer, D-penicillamine, dimercaprol.</em></p>
<p><strong><em>[1 mark]</em></strong></p>
<div class='question_part_label'>f.</div>
</div>
